Polymorphisms of heat shock protein-70 (HSPA1B and HSPA1L loci) do not influence infection or outcome risk in critically ill surgical patients

Shock

Volumn 25, Issue 2, 2006, Pages 117-122

  Bowers, Daniel J ^a   Calvano, Jacqueline E ^a   Alvarez, Sonia M ^a   Coyle, Susette M ^a   Macor, Marie A ^a   Kumar, Ashwini ^a   Calvano, Steve E ^a   Lowry, Stephen F ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Critical care; Genetic polymorphisms; Heat shock protein 70; Inflammation; Multiple organ failure; Sepsis syndrome

Indexed keywords

AGED; CRITICAL ILLNESS; CROSS INFECTION; FEMALE; HSP70 HEAT-SHOCK PROTEINS; HUMANS; INTENSIVE CARE; LYMPHOTOXIN-ALPHA; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; QUANTITATIVE TRAIT LOCI; RISK FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33646802667     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.shk.0000190826.36406.27     Document Type: Article

References (37)

1. Balla A, Toth B, Timar G, Bak J, Krajcsi P: Molecular targets for pharmacological cytoprotection. Biochem Pharmacol 61:769-777, 2001.
2. Braun S, auf dem Keller U, Steiling H, Werner S: Fibroblast growth factors in epithelial repair and cytoprotection. Philos Trans R Soc Lond B Biol Sci 359:753-757, 2004.
3. Morimoto RI, Santoro MG: Stress-inducible responses and heat shock proteins: new pharmacologic targets for cytoprotection. Nat Biotechnol 16:833-838, 1998.
4. Wankell M, Werner S, Alzheimer C, Werner S: The roles of activin in cytoprotection and tissue repair. Ann N Y Acad Sci 995:48-58, 2003.
5. Prohaszka Z, Fust G: Immunological aspects of heat shock proteins: the optimum stress of life. Mol Immunol 41:29-44, 2004.
6. Christians ES, Yan L-J, Benjamin IJ: Heat shock factor 1 and heat shock proteins: critical partners in protection against acute cell injury. Crit Care Med 30:S43-S50, 2002.
7. Milner CM, Campbell RD: Structure and expression of the three MHC-linked HSP70 genes. Immunogenetics 32:242-251, 1992.
8. Milner CM, Campbell RD: Polymorphic analysis of the three MHC-linked HSP70 genes. Immunogenetics 36:357-362, 1992.
9. Pociot F, Ronningen KS, Nerup J: Polymorphic analysis of the human MHC-linked heat shock protein 70 (HSP70-2) and HSP70-Hom genes in insulin-dependent diabetes mellitus (IDDM). Scand J Immunol 38:491-495, 1993.
10. Mestiri S, Bouaouina N, Ahmed SB, Khedhaier A, Jrad BB, Remadi S, Chouchane L: Genetic variation in the tumor necrosis factor-α promoter region and in the stress protein HSP70-2. Cancer 91:872-878, 2001.
11. Chouchane L, Ahmed SB, Baccouche S, Remadi S: Polymorphism in the tumor necrosis factor-α promoter region and in the heat shock protein 70 genes associated with malignant tumors. Cancer 80:1489-1496, 1997.
12. Schroder O, Schulte KM, Ostermann P, Roher HD, Ekkernkamp A, Laun RA: Heat shock protein 70 genotypes HSPA1B and HSPA1L influence cytokine concentrations and interfere with outcome after major injury. Crit Care Med 31:73-79, 2003.
13. Schroeder S, Reck M, Hoeft A, Stuber F: Analysis of two human leukocyte antigen-linked polymorphic heat shock protein 70 genes in patients with severe sepsis. Crit Care Med 27:1265-1270, 1999.
14. Balog A, Gal J, Gyulai Z, Zsilak S, Mandi Y: Tumour necrosis factor-α and heat-shock protein 70-2 gene polymorphisms in a family with rheumatoid arthritis. Acta Microbiol Immunol Hung 51:263-269, 2004.
15. Calvano JE, Um JY, Agnese DM, Hahm SJ, Kumar A, Coyle SM, Calvano SM, Lowry SF: Influence of the TNF-α and TNF-β polymorphisms upon infectious risk and outcome in surgical intensive care patients. Surg Infect 4:163-169, 2003.
16. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, Reinhart CK, Suter PM, Thijs LG: The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. Intensive Care Med 22:707-710, 1996.
17. Salvo I, de Cian W, Musicco M, Langer M, Piadena R, Wolfler A, Montani C, Magni E: The Italian SEPSIS study: preliminary results on the incidence and evolution of SIRS, sepsis, severe sepsis and septic shock. Intensive Care Med 21:S244-S249, 1995.
18. Brown PE, McClave SA, Hoy NW, Short AF, Sexton LK, Meyer KL: The Acute Physiology and Chronic Health Evaluation II classification system is a valid marker for physiologic stress in the critically ill patient. Crit Care Med 21:363-367, 1993.
19. Nemzek JA, Siddiqui J, Remick DG: Development and optimization of cytokine ELISAs using commercial antibody pairs. J Immunol Methods 255:149-157, 2001.
20. Oberholzer A, Souza SM, Tschoeke SK, Oberholzer C, Abouhamze A, Pribble JP, Moldawer LL: Plasma cytokine measurements augment prognostic scores as indicators of outcome in patients with severe sepsis. Shock 23:488-493, 2005.
21. Dofferhoff AS, Bom VJ, de Vries-Hospers HG, van Ingen J, vd Meer J, Hazenberg BP, Mulder PO, Weits J: Patterns of cytokines, plasma endotoxin, plasminogen activator inhibitor, and acute phase proteins during the treatment of severe sepsis in humans. Crit Care Med 20:185-192, 1992.
22. Peck R, Olsen C, Devore JL: Introduction to Statistics and Data Analysis, ed 2. Belmont, CA: Thomson-Brooks/Cole, 2005.
23. Santoro MG: Heat shock factors and the control of the stress response. Biochem Pharmacol 59:55-63, 2001.
24. Bruemmer-Smith S, Stuber F, Schroeder S: Protective functions of intracellular heat shock protein (HSP) 70-expression in patients with severe sepsis. Intensive Care Med 27:1835-1841, 2001.
25. + T cells. J Immunol 173:5130-5137, 2004.
26. Zheng L, He M, Long M, Blomgran R, Stendahl O: Pathogen-induced apoptotic neutrophils express heat shock proteins and elicit activation of human macrophages. J Immunol 173:6319-6326, 2004.
27. Beere HM, Green DR: Stress management: heat shock protein 70 and the regulation of apoptosis. Trends Cell Biol 11:6-10, 2001.
28. Van Molle W, Wielockx B, Mahieu T, Takada M, Taniguchi T, Sekikawa K, Libert C: HSP70 protects against TNF-induced lethal inflammatory shock. Immunity 16:685-695, 2002.
29. Hashiguchi N, Ogura H, Tanaka H, Koh T, Nakamori Y, Noborio M, Shiozaki T, Nishino M, Kuwagata Y, Shimazu T, Sugimoto H: Enhanced expression of heat shock protein in activated polymorphonuclear leukocytes in patients with sepsis. J Trauma 51:1104-1109, 2001.
30. Ding XZ, Fernandez-Prada CM, Bhattacharjee AK, Hoover DL: Overexpression of HSP-70 inhibits bacterial lipopolysaccharide-induced production of cytokines in human monocyte-derived macrophages. Cytokine 16:210-219, 2001.
31. Schroeder S, Lindemann C, Hoeft A, Putensen C, Decker D, von Ruecker AA, Stuber F: Impaired inducibility of heat shock protein 70 in peripheral blood lymphocytes of patients with severe sepsis. Crit Care Med 27:1080-1084, 1999.
32. Schroeder S, Bischoff J, Lehmann LE, Hering R, von Spiegel T, Putensen C, Hoeft A, Stuber F: Endotoxin inhibits heat shock protein 70 (HSP70) expression in peripheral blood mononuclear cells of patients with severe sepsis. Intensive Care Med 25:52-57, 1999.
33. Durand P, Bachelet M, Brunet F, Richard MJ, Dhainaut J-F, Dall'ava J, Polla BS: Inducibility of the 70-kD heat shock protein in peripheral blood monocytes is decreased in human acute respiratory distress syndrome and recovers over time. Am J Respir Crit Care Med 161:286-292, 2000.
34. Mandell GL, Bennett JE, Dolin R: Principles and Practice of Infectious Diseases, ed 5. Philadelphia: Churchill Livingston, 2000.
35. Men X, Harken AH: The interaction between HSP70 and TNF-α expression: a novel mechanism for protection of the myocardium against postinjury depression. Shock 17:345-353, 2002.
36. Stuber F, Petersen M, Bokelmann F, Shade U: A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-α concentrations and outcome of patients with severe sepsis. Crit Care Med 24:381-384, 1996.
37. Majetschak M, Flohe S, Obertacke U, Schroder J, Staubach K, Nast-Kolb D, Schade FU, Stuber F: Relation of a TNF gene polymorphism to severe sepsis in trauma patients. Ann Surg 230:207-214, 1999.